Tizon, Candido T.
HRN: 14-84-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/06/2024
08/12/2024
IVT
4.5g
Q6
CAP MR; Pseudomonas
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes